Compounded Ozempic: What You're Actually Buying in 2026

Is there actually such a thing as "compounded Ozempic"?

No — and it's worth being direct about that before anything else. Ozempic is Novo Nordisk's trademarked, FDA-approved brand name for a specific semaglutide injection, approved for type 2 diabetes. A trademark protects that exact finished product: the brand name, Novo Nordisk's manufacturing process, and the FDA's review of it as a whole. A compounding pharmacy has no legal path to copy that finished product and sell it under Novo Nordisk's name. What a licensed pharmacy can do is compound the active molecule itself, semaglutide, under its own generic name, for a specific patient with a documented reason the commercial product doesn't meet. When a telehealth ad says "compounded Ozempic," it's either using sloppy shorthand for compounded semaglutide, or it's misrepresenting what it sells — and the difference matters.

Novo Nordisk has been aggressive about defending that line. The company has filed well over 100 lawsuits against compounding pharmacies, med spas, and telehealth sellers across dozens of states, and in April 2025 won a permanent injunction against one compounding pharmacy that had marketed knockoff drugs as Ozempic or Wegovy — the court also ordered corrective disclosures telling patients the products were never FDA-reviewed. In February 2026, the company filed suit against telehealth provider Hims & Hers over patent claims tied to its compounded semaglutide products. None of this means compounded semaglutide itself is fake or illegal; it means selling it under the Ozempic name specifically is the part Novo Nordisk keeps winning in court.

• Ozempic = Novo Nordisk's trademarked, FDA-approved brand of semaglutide — cannot legally be compounded or sold under that name by anyone else.
• Compounded semaglutide = the same active molecule, mixed by a licensed 503A pharmacy for an individual patient — legally a different, non-branded product.
• A provider marketing "compounded Ozempic" as a product name, rather than clearly saying "compounded semaglutide," is misusing a trademark and worth a second look.

Is compounding semaglutide legal in 2026?

Yes, but only through a narrower door than during the 2022–2024 shortage years. Semaglutide was on the FDA's drug shortage list, which let compounding pharmacies produce it broadly for anyone who wanted it. The FDA declared that shortage resolved on February 21, 2025, and after a court declined to block the change, enforcement discretion for 503A pharmacies ended April 22, 2025, with 503B outsourcing facilities following on May 22, 2025.

What survived is the 503A individual-patient pathway. A state-licensed compounding pharmacy can still legally prepare semaglutide for a specific, named patient when a prescriber documents a genuine clinical reason the commercial drug won't work — a documented allergy to an inactive ingredient, for instance. Wanting a lower price than Ozempic isn't, on its own, a qualifying reason under current FDA guidance, even though cost is the reason most people end up here. On April 30, 2026, the FDA separately proposed excluding semaglutide (along with tirzepatide and liraglutide) from the 503B bulk substances list entirely; the comment period was extended and closed July 30, 2026, and no final rule has been issued as of this writing. That proposal is about 503B bulk compounding, which had already wound down — it doesn't touch the 503A pathway the providers below use.

How much less does compounded semaglutide cost than brand-name Ozempic?

This is the actual money question, and it's a real gap. At full retail with no savings program, Ozempic's list price runs roughly $1,028 to $1,100 a month — Novo Nordisk has also announced future list-price cuts, so expect this number to keep moving; see Ozempic cost for the full pathway breakdown. Commercially insured patients with a type 2 diabetes diagnosis can use the NovoCare savings card to get that down to around $25 a month. Without insurance, Novo Nordisk's own self-pay program starts at $199 a month for the first two fills, then settles at $349 to $499 a month at maintenance doses.

Compounded semaglutide, by contrast, runs about $150 to $300 a month all-in across the reputable providers below — cash-pay, with no insurance billing possible on either side.

• Full retail Ozempic, no savings: roughly $12,300 to $13,200 a year.
• NovoCare self-pay at 1mg maintenance ($349/mo): roughly $4,188 a year.
• Compounded semaglutide at the lower end of this list ($150–$178/mo): roughly $1,800 to $2,136 a year — about $2,000 to $2,400 less than NovoCare self-pay, and roughly $10,000 less than full retail.
• Commercially insured T2D patients on the NovoCare card (~$25/mo): the cheapest path of all, and compounded semaglutide won't beat it.

Where to find a reliable ozempic-alternative compounding pharmacy

The table above covers five providers we could verify compound semaglutide under the 503A model, with dated, all-in prices rather than a teaser number. This page keeps things brief; for the exhaustive provider-by-provider comparison — pros, cons, and every fee line — see compounded semaglutide.

Henry Meds

Fully bundled pricing (visits, supplies, shipping) that doesn't rise as you titrate up — oral from $249/mo, injection from $297/mo. The figure we've seen hold steadiest across our checks of this category.

Mochi Health

Splits billing into a flat $99/mo medication fee and a separate ~$79/mo membership, for about $178/mo all-in — cheaper than it first looks once you add the two lines together.

Fridays

Bundles coaching and dietitian access into the price. Cheapest on a 12-month prepay (~$150/mo); month-to-month runs closer to $249/mo.

Eden

No membership fee, and one flat rate at every dose so the price doesn't climb as you titrate up. The catch is in the timing: the ~$149/mo figure is a discounted first month, and the ongoing rate settles closer to $249/mo from month two on.

Peak Wellness

Also flat across doses with no membership add-on, landing around $165 to $249/mo. The lower end of that range requires prepaying multiple months at once — worth confirming which rate your specific plan locks in before you commit.

Is compounded semaglutide the same quality and safety as Ozempic?

Same active molecule, different oversight. The FDA reviews Ozempic's potency, sterility, and manufacturing consistency batch to batch; it does not review a compounded formulation the same way. That's the practical meaning of "not FDA-approved as a finished product" — no independent agency has verified that your specific vial matches the last one. Some compounded formulations also add ingredients Ozempic doesn't contain, most often B12 or L-carnitine, marketed for energy or metabolism support but not independently evaluated in combination with semaglutide. None of this makes compounded semaglutide inherently unsafe, but it makes the specific pharmacy behind your prescription, not just the telehealth brand on the label, the thing worth actually asking about.

Red flags: how to spot a legit vs. sketchy compounding pharmacy

• Won't name the 503A pharmacy filling your prescription, or dodges the question when you ask.
• No online consult or clinical review at all — just a checkout page and a shipment.
• Markets the product literally as "compounded Ozempic" rather than compounded semaglutide.
• Maintenance-dose pricing that isn't published anywhere, even after you ask directly.
• A price meaningfully below everything else on this page with no explanation for how that's possible.

Who compounded semaglutide is — and isn't — a good fit for

• Good fit: women without insurance coverage for GLP-1 medications who want supervised semaglutide at the lowest realistic cash-pay cost, and who've confirmed a documented clinical reason with their provider.
• Not ideal: commercially insured women with a type 2 diabetes diagnosis — the NovoCare savings card on brand-name Ozempic will very likely beat any compounded price.
• Always ask: which 503A pharmacy compounds your medication, and what its accreditation and testing practices are.

If weight change in your forties or fifties is what brought you to semaglutide in the first place, the hormonal piece is worth understanding on its own terms — see GLP-1 medications and menopause weight gain for that fuller picture.